Response to the Comment on "Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial"
- PMID: 31714314
- DOI: 10.1097/SLA.0000000000003675
Response to the Comment on "Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial"
Comment on
-
Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension: A Randomized Trial.Ann Surg. 2019 Jun;269(6):1025-1033. doi: 10.1097/SLA.0000000000003062. Ann Surg. 2019. PMID: 31082898 Clinical Trial.
-
Comment on "Somatostatin as Inflow Modulator in Liver-transplant Recipients With Severe Portal Hypertension-A Randomized Trial".Ann Surg. 2020 May;271(5):e121-e122. doi: 10.1097/SLA.0000000000003680. Ann Surg. 2020. PMID: 31688273 No abstract available.
References
-
- Troisi RI, Vanlander A, Giglio MC, et al. Somatostatin as inflow modulator in liver-transplant recipients with severe portal hypertension. Ann Surg 2018; doi:10.1097/SLA.0000000000003062. - DOI
-
- Troisi R, Ricciardi S, Smeets P, et al. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant 2005; 5:1397–1404.
-
- Troisi R, Cammu G, Militerno G, et al. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg 2003; 237:429–436.
-
- Reynaert H, Rombouts K, Vandermonde A, et al. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut 2004; 53:1180–1189.
-
- Troisi RI, Sainz-Barriga M. Successful transplantation of small-for-size grafts: a reappraisal. Liver Transplant 2012; 18:270–273.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources